what to expect when switching from semaglutide to tirzepatide Early Dose Escalation of after in Type 2 Diabetes Mellitus Switching from Semaglutide to Tirzepatide

FDA and EMA approvals are down in 2025 as major US and EU reforms shift pricing and access

Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to a new RANDreport

Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide

PlexusDx provides detailed guidance to help beginners build confidence and inject safely from day one

Researchers just launched a clinical study called Meow-1 using GLP-1 weight loss drugs in cats.

Lot 6040411 COA issued 07/06/2026 Independent lab-verified data for potency, heavy metals & microbiology